Legal & General Group Plc Has $224.45 Million Stake in Humana Inc. $HUM

Key Points

• Legal & General Group Plc cut its Humana stake by 4.6% in the fourth quarter, but still held 876,325 shares worth about $224.45 million. Institutional investors remain heavily involved, owning 92.38% of Humana’s stock.
• Humana reported better-than-expected quarterly results, with EPS of $10.31 versus $9.97 expected and revenue of $39.65 billion. The company also raised attention with its FY 2026 guidance and continued strong year-over-year revenue growth.
• The insurer announced a quarterly dividend of $0.885 per share, implying a $3.54 annual payout and a 1.2% yield. Wall Street is mixed on the stock, with a consensus rating of Hold and an average price target of $270.48.

Legal & General Group Plc decreased its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 4.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 876,325 shares of the insurance provider's stock after selling 42,629 shares during the quarter. Legal & General Group Plc owned about 0.73% of Humana worth $224,453,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Glenview Trust Co boosted its stake in Humana by 40.8% during the 4th quarter. Glenview Trust Co now owns 53,692 shares of the insurance provider's stock worth $13,752,000 after acquiring an additional 15,559 shares during the last quarter. Swedbank AB boosted its stake in Humana by 6.2% during the 4th quarter. Swedbank AB now owns 111,803 shares of the insurance provider's stock worth $28,636,000 after acquiring an additional 6,534 shares during the last quarter. William Blair Investment Management LLC boosted its stake in Humana by 14.0% during the 4th quarter. William Blair Investment Management LLC now owns 43,877 shares of the insurance provider's stock worth $11,238,000 after acquiring an additional 5,382 shares during the last quarter. Jefferies Financial Group Inc. boosted its stake in Humana by 152.0% during the 4th quarter. Jefferies Financial Group Inc. now owns 6,164 shares of the insurance provider's stock worth $1,579,000 after acquiring an additional 3,718 shares during the last quarter. Finally, Pzena Investment Management LLC boosted its stake in Humana by 1.0% during the 4th quarter. Pzena Investment Management LLC now owns 4,072,208 shares of the insurance provider's stock worth $1,043,015,000 after acquiring an additional 41,125 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Humana Stock Performance

Shares of HUM stock opened at $307.13 on Thursday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The company has a market capitalization of $36.87 billion, a P/E ratio of 32.85, a price-to-earnings-growth ratio of 2.19 and a beta of 0.68. The company's 50 day moving average price is $226.50 and its two-hundred day moving average price is $228.10. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $315.66.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. During the same period last year, the company earned $11.58 earnings per share. The firm's revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. On average, analysts expect that Humana Inc. will post 9.01 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. Humana's dividend payout ratio (DPR) is currently 37.86%.

Wall Street Analysts Forecast Growth

HUM has been the topic of several recent analyst reports. Guggenheim lifted their price objective on shares of Humana from $252.00 to $269.00 and gave the stock a "buy" rating in a research note on Thursday, April 30th. Raymond James Financial reissued an "outperform" rating and set a $260.00 price objective on shares of Humana in a research note on Friday, May 1st. Weiss Ratings reissued a "sell (d+)" rating on shares of Humana in a research note on Tuesday, April 21st. Leerink Partners raised their target price on shares of Humana from $185.00 to $255.00 and gave the stock a "market perform" rating in a report on Thursday, April 30th. Finally, Zacks Research upgraded shares of Humana from a "strong sell" rating to a "hold" rating in a report on Wednesday, May 13th. Nine analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $270.48.

Humana Company Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.